FindTrial
Sign In

Pharmaceutical Form: Tablet

3 trials

Sponsors

GBG Forschungs GmbH, Salford Royal Hospital, National Institute of Health and the Environment (Dutch acronym: RIVM)

Conditions

Lyme disease MedDRA version: 14.1 Level: PT Classification code 10025169 Term: Lyme disease System Organ Class: 10021881 - Infections and infestationsSecondary hyperparathyroidism in renal failurepatients with HER2 negative metastatic breast cancer

Phase 4

A randomised control trial to identify the effects of cinacalcet on bone and cardiovascular health in end-stage renal disease - cinacalcet study
Active, not recruitingEUCTR2005-003871-19-GB
Salford Royal HospitalSecondary hyperparathyroidism in renal failure
Start: 2006-09-19Target: 40Updated: 2019-11-25
Tick Test & Prophylaxis Proof
Active, not recruitingEUCTR2012-005101-51-NL
National Institute of Health and the Environment (Dutch acronym: RIVM)Lyme disease MedDRA version: 14.1 Level: PT Classification code 10025169 Term: Lyme disease System Organ Class: 10021881 - Infections and infestations
Start: 2013-02-05Target: 2500Updated: 2023-10-03

Unknown Phase

A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer - Monica Study
Active, not recruitingEUCTR2005-000074-51-DE
GBG Forschungs GmbHpatients with HER2 negative metastatic breast cancer
Start: 2005-05-03Updated: 2015-02-16